Radiotherapy combined with anti-PD-1 promotes tumor cell phagocytosis by DCs, increases tumor-associated antigen presentation, and further promotes tumor-specific CD8+ T cells priming in colorectal cancer. Here, PDCD1 is linked to neoplasm.